Identifying differentially expressed genes and pathways in two types of non-small cell lung cancer: Adenocarcinoma and squamous cell carcinoma

Genetics and Molecular Research

Volumn 13, Issue 1, 2014, Pages 95-102

  Liu, J ^a   Yang, X Y ^a   Shi, W J ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Adenocarcinoma; Differentially expressed genes; Non small cell lung cancer; Squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; S PHASE KINASE ASSOCIATED PROTEIN 2;

ARTICLE; CANCER CLASSIFICATION; CDK1 GENE; CDK2 GENE; CDK4 GENE; CELL DIVISION; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; DIFFERENTIALLY EXPRESSED GENE; GENE; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; SKP2 GENE;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; CDC2 PROTEIN KINASE; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; METABOLIC NETWORKS AND PATHWAYS; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 84892146653     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2014.January.8.8     Document Type: Article

References (29)

1. American Thoracic Society (ATS) and European Respiratory Society (ERS) (1997). Pretreatment evaluation of non-small-cell lung cancer. Am. J. Respir. Crit. Care Med. 156: 320-332.
2. Agulló-Ortuño MT, Lopez-Rios F and Paz-Ares L (2010). Lung cancer genomic signatures. J. Thorac. Oncol. 5: 1673-1691.
3. Balko JM and Arteaga CL (2012). Molecular signatures of lung cancer: defining new diagnostic and therapeutic paradigms. Mol. Diagn. Ther. 16: 1-6.
4. Bishop JA, Benjamin H, Cholakh H, Chajut A, et al. (2010). Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin. Cancer Res. 16: 610-619.
5. Dacic S, Flanagan M, Cieply K, Ramalingam S, et al. (2006). Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Am. J. Clin. Pathol. 125: 860-865.
6. Daraselia N, Wang Y, Budoff A and Lituev A (2011). Pathway analysis of primary human non-small cell lung cancer (NSCLC). J. Clin. Oncol. (Meeting Abstracts) 29: 15-Suppl. 10573.
7. Daraselia N, Wang Y, Budoff A, Lituev A, et al. (2012). Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers. Am. J. Cancer Res. 2: 93-103.
8. Dehan E, Ben-Dor A, Liao W, Lipson D, et al. (2007). Chromosomal aberrations and gene expression profiles in non-small cell lung cancer. Lung Cancer 56: 175-184.
9. Ferlay J, Autier P, Boniol M, Heanue M, et al. (2007). Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18: 581-592.
10. Hou J, Aerts J, den Hamer B, van Ijcken W, et al. (2010). Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One 5: e10312.
11. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, et al. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
12. Kanehisa M and Goto S (2000). KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28: 27-30.
13. Kawana H, Tamaru J, Tanaka T, Hirai A, et al. (1998). Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer. Am. J. Pathol. 153: 505-513.
14. Kettunen E, Anttila S, Seppanen JK, Karjalainen A, et al. (2004). Differentially expressed genes in nonsmall cell lung cancer: expression profiling of cancer-related genes in squamous cell lung cancer. Cancer Genet. Cytogenet. 149: 98-106.
15. Kim MJ, Shin HC, Shin KC and Ro JY (2013). Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens. Ann. Diagn. Pathol. 17: 85-90.
16. Kuner R, Muley T, Meister M, Ruschhaupt M, et al. (2009). Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung Cancer 63: 32-38.
17. Nacht M, Dracheva T, Gao Y, Fujii T, et al. (2001). Molecular characteristics of non-small cell lung cancer. Proc. Natl. Acad. Sci. U. S. A. 98: 15203-15208.
18. Nacht M, Dracheva T, Sidransky D, Madden SL, et al. (2010). Molecular characteristics of non-small cell lung cancer. Google Patents.
19. Niklinska W, Chyczewski L, Laudanski J, Sawicki B, et al. (2001). Detection of P53 abnormalities in non-small cell lung cancer by yeast functional assay. Folia Histochem. Cytobiol. 39: 147-148.
20. R Development Core Team (2008). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna.
21. Scagliotti GV, Parikh P, von Pawel J, Biesma B, et al. (2008). Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J. Clin. Oncol. 26: 3543-3551.
22. Smyth GK (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3: Article3.
23. Sudo M, Chin TM, Mori S, Doan NB, et al. (2013). Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer. Cancer Chemother. Pharmacol. 71: 1325-1334.
24. Terry J, Leung S, Laskin J, Leslie KO, et al. (2010). Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am. J. Surg. Pathol. 34: 1805-1811.
25. The Gene Ontology Consortium (2008). The Gene Ontology project in 2008. Nucleic Acids Res. 36: D440-D444.
26. Tjalma WA, Van Waes TR, Van den Eeden LE and Bogers JJ (2005). Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix. Best. Pract. Res. Clin. Obstet. Gynaecol. 19: 469-483.
27. Yokoi S, Yasui K, Mori M, Iizasa T, et al. (2004). Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes. Am. J. Pathol. 165: 175-180.
28. Yu G, Wang LG, Han Y and He QY (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16: 284-287.
29. Zhang YK, Zhu WY, He JY, Chen DD, et al. (2012). miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes. J. Cancer Res. Clin. Oncol. 138: 1641-1650.